Evaluation of renal markers and liver enzymes in patients infected with the Chikungunya virus

J Med Virol. 2023 Dec;95(12):e29276. doi: 10.1002/jmv.29276.


Chikungunya virus (CHIKV) is an arbovirus (Togaviridae family, Alphavirus genus) that was first identified in 1953 in Tanzania. In 2014, the Asian and East/Central/South/African (ECSA) genotypes were identified in Brazil, although the genotype that spread the most in the following years across the Brazilian territory was the ECSA. The clinical symptoms associated with the infection caused by CHIKV include mainly fever, myalgia, headache, and arthralgia. In infections caused by other arboviruses (such as the ones caused by Dengue and West Nile viruses), changes in biochemical markers are often observed. This study aims to evaluate the biochemical markers profile of kidney and liver injury in acute patients infected with CHIKV. Two groups of correlations were found between the variables analyzed, namely, one between liver enzymes (r = 0.91), and another for kidney markers (r = 0.54-0.66). A significant elevation in the percentage of altered creatinine in CHIKV-infected patients was observed, followed by uric acid and AST. Altogether, in 8 different comparisons, it was possible to observe statistically significant differences between the levels of the markers when compared to the manifestation of symptoms (presence and absence). These noticeable changes in marker measurements could potentially be connected to the range of clinical symptoms seen in the disease.

Keywords: Chikungunya virus infection; liver enzymes; renal markers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arboviruses*
  • Biomarkers
  • Chikungunya Fever* / diagnosis
  • Chikungunya virus* / genetics
  • Genotype
  • Humans
  • Phylogeny


  • Biomarkers